We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca Transfers Hypertension Drugs to Cheplapharm for $400 Million
AstraZeneca Transfers Hypertension Drugs to Cheplapharm for $400 Million
AstraZeneca is selling off the global rights for two hypertension drugs, Atacand and Atacand Plus, to German drugmaker Cheplapharm Arzneimittel in a $400 million deal covering 70 countries.